Market Research Logo

Czech Republic Pharmaceuticals and Healthcare Report Q2 2016

Czech Republic Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The Czech Republic will continue to be one of the most attractive markets in the CEE region forpharmaceutical and healthcare investment. A strong economic outlook will be the driving factor behindgrowth, with plans to further increase access to healthcare; pharmaceutical sales are expected to increaseover the coming years.

Headline Expenditure Projections

Pharmaceuticals: CZK78.83bn (USD3.01bn) in 2015 to CZK81.10bn (USD3.27bn) in 2016; +2.9% inlocal currency terms and +8.6 % in US dollar terms. Forecasts in line with last quarter.

Healthcare: CZK284.72bn (USD10.87bn) in 2015 to CZK292.53bn (USD11.79bn) in 2016; +2.7% inlocal currency terms and +8.4% in US dollar terms. Forecasts in line with last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Czech Republic 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Czech Republic 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Czech Republic 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Czech Republic 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Czech Republic 2014-2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index - Q2 2016
Czech Republic - Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Regime
Pricing Regime
Reimbursement Regime
Table: European VAT Rates On Medicines (%)
Market Overview
Healthcare Sector
Table: Healthcare Resources (Czech Republic 2010-2015)
Table: Healthcare Personnel (Czech Republic 2010-2015)
Table: Healthcare Activity (Czech Republic 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Zentiva (Sanofi)
Demographic Data
Demographic Forecast
Table: Population Headline Indicators (Czech Republic 1990-2025)
Table: Key Population Ratios (Czech Republic 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Czech Republic 1990-2025)
Table: Population By Age Group (Czech Republic 1990-2025)
Table: Population By Age Group % (Czech Republic 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report